期刊文献+

观察不同性别胃肠道肿瘤患者化疗的不良反应 被引量:1

Clinical observation of adverse reactions of chemotherapy in different gender patients with gastrointestinal tract tumor
原文传递
导出
摘要 目的 观察不同性别胃肠道肿瘤患者在化疗中不良反应的特点.方法 选取行FOLFOX4化疗方案治疗的79例胃肠道肿瘤患者,其中女38例,男41例.按性别分组,观察整个化疗过程中不良反应的情况.结果 女性与男性恶心、呕吐比较差异有统计学意义(P =0.007);腹泻(P=0.585)、口腔黏膜炎(P=0.393)、脱发(P=0.269)、神经系统毒性(P=0.212)、心脏节律改变(P=0.618)、皮疹(P=0.309)、白细胞减少(P =0.255)、血红蛋白减少(P=0.231)、血小板减少(P=0.194)、丙氨酸氨基转移酶升高(P=0.585)、肌酐升高(P=0.514)等不良反应比较差异未见统计学意义.结论 女性与男性相比,化疗中恶心、呕吐的发生率高,程度重. Objective To investigate the characteristics of adverse reactions of chemotherapy in different gender patients with gastrointestinal tumor.Methods Seventy-nine cases of gastrointestinal cancer received FOLFOX4 chemotherapy,including 38 cases of female,41 cases of male.Grouped by gender,the adverse reactions of chemotherapy in the whole process were observed.Results Females compared with males,the difference of nausea and vomiting was statistically significant (P =0.007);diarrhea (P =0.585),oral mucositis (P =0.393),alopecia (P =0.269),nervous system toxicity (P =0.212),heart rhythm changing (P =0.618),rash (P =0.309),white blood cells decreasing (P =0.255),hemoglobin decreasing (P =0.231),thrombocytopenia decreasing (P =0.194),alanine aminotransferase increasing (P =0.585),creatinine increasing (P =0.514) had no significant difference between the other adverse reactions.Conclusions Compared with men and women,the incidence of nausea,vomiting is high,and is severe.
出处 《中国实用医刊》 2015年第7期55-57,共3页 Chinese Journal of Practical Medicine
关键词 性别 胃肠道肿瘤 化疗 不良反应 Gender Gastrointestinal tumor Chemotherapy Adverse reaction
  • 相关文献

参考文献5

二级参考文献42

  • 1王更利,尹绪德,姚文秀,傅彬玉,王谊.昂丹司琼和甲氧氯普胺在肿瘤化学疗法时作为止吐剂的对比[J].新药与临床,1994,13(6):350-352. 被引量:2
  • 2李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Gellner K, Eiselt R, Hustert E, et al. Genomic organization of the human CYP3A locus: identification of a new,inducible CYP3A gene[J].Pharmacogenetics,2001,11(2) :111-121
  • 5Parkinson A,Mudra DR,Johnson C,et al. The effects of gender,age,ethnicity,and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes [J]. Toxicol Appl Pharmacol,2004,199 (3) : 193-209
  • 6MacLeod SL,Nowell S,Massengill J,et al. Cancer therapy and polymorphisms of cytochromes P450[J]. Clin Chem Lab Med,2000,38(9) :883-887
  • 7Schwarz UI. Clinical relevance of genetic polymorphisms in the human CYP2C9 gene[J]. Eur J Clin Invest,2003 ,33( Suppl 2) :23-30
  • 8Walsky RL, Obach RS, Gaman EA, et al. Selective inhibition of human cytochrome P4502C8 by montelukast [J]. Drug Metab Dispos, 2005,33 (3) :413-418
  • 9Yamaguchi K, Arai Y. Kanda Y, et al.Germline mutation of dihydropyrimidine dehydrogenese gene among a Japanese population in relation to toxicity to 5-Fluorouracil [J]. Jpn J Cancer Res ,2001,92 (3) :337-342
  • 10McLeod HI, Krynetski EY,Relling MV, et al. Genetic polymorphism of thiopurine methyltransferase and its clinical rele-vance for childhood acute lymphoblastic leukemia[J].Leukemia,2000,14 (4) :567-572

共引文献376

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部